| Dr Kenneth L Orwick, MD | |
|
325 Park St, Lebanon, OR 97355-4229 | |
| (541) 451-7200 | |
| (541) 451-7207 |
| Full Name | Dr Kenneth L Orwick |
|---|---|
| Gender | Male |
| Speciality | Family Medicine - Geriatric Medicine |
| Location | 325 Park St, Lebanon, Oregon |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336181106 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD11689 (Oregon) | Primary |
| 207QG0300X | Family Medicine - Geriatric Medicine | MD11689 (Oregon) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kenneth L Orwick, MD 325 Park St, Lebanon, OR 97355-4229 Ph: (541) 451-7200 | Dr Kenneth L Orwick, MD 325 Park St, Lebanon, OR 97355-4229 Ph: (541) 451-7200 |
News Archive
Two United Nations Population Fund (UNFPA) conferences this week in Addis Ababa, Ethiopia, gathered "international policymakers, government ministers, and lawmakers" to address the half a million maternal deaths annually, Radio Free Europe/Radio Liberty reports. Although the U.N. "hopes to reduce maternal mortality by three quarters between 1990 and 2015," this Millennium Development Goal target "has seen the least progress in recent years," the news organization writes.
If the blood of a pregnant woman is rhesus-negative and the blood of the fetus is rhesus-positive, the woman may develop antibodies, which can cause severe harm to subsequent children in particular.
A recent study by US researchers reveals that brilacidin, a small synthetic molecule with peptide-like properties, exerts potent in vitro antiviral activity against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – both as a standalone treatment and in combination with FDA-approved remdesivir. The study is currently available on the bioRxiv preprint server.
Shire plc, the global specialty biopharmaceutical company, today announced topline results from FAST-3 (For Angioedema Subcutaneous Treatment), the largest of the Phase III trials studying the use of Firazyr (icatibant) for treatment of acute attacks of hereditary angioedema (HAE).
› Verified 7 days ago
Heather Christianson, Family Medicine Medicare: Medicare Enrolled Practice Location: 200 Mullins Dr, Lebanon, OR 97355 Phone: 541-259-0200 | |
Patricia Ann Harding, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 39127 Griggs Dr, Lebanon, OR 97355 Phone: 541-451-2613 | |
Keith Messenger, Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 200 Mullins Dr, Lebanon, OR 97355 Phone: 541-259-0200 | |
Dr. Morgan Cameron Wimmer, Family Medicine Medicare: Medicare Enrolled Practice Location: 675 N 5th St Ste 200, Lebanon, OR 97355 Phone: 541-451-6282 | |
Dr. Thad L. Nelson, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 325 Park St, Lebanon, OR 97355 Phone: 541-451-7200 Fax: 541-451-7207 | |
Gina Ann Miller, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 425 N Santiam Hwy, Lebanon, OR 97355 Phone: 541-451-6960 Fax: 541-451-7271 | |
Dr. Andrew Winge, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 525 N Santiam Hwy, Lebanon, OR 97355 Phone: 541-258-2101 |